Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 3STRIDES PHARMA INTL
02 3MANKIND PHARMA
03 6AMNEAL
04 3ANDAS 5 HOLDING
05 1ANI PHARMS
06 3AUROBINDO PHARMA LTD
07 1AZURITY
08 2HERITAGE
09 3HIBROW HLTHCARE
10 3IMPAX
11 2IVAX SUB TEVA PHARMS
12 3LANNETT CO INC
13 4MAIA PHARMS INC
14 2METACEL PHARMS LLC
15 3MICRO LABS
16 3NORTHSTAR HLTHCARE
17 2NOVARTIS
18 2OXFORD PHARMS
19 2PH HEALTH
20 6PHARMOBEDIENT
21 4PIRAMAL CRITICAL
22 3REGCON HOLDINGS
23 6RISING
24 9RUBICON RESEARCH
25 3SOMERSET THERAPS LLC
26 2SUN PHARM INDS INC
27 2TEVA
28 2UCB INC
29 3UNICHEM
30 2USL PHARMA
31 6WATSON LABS
32 2YILING
33 4ZYDUS LIFESCIENCES
34 1Blank
01 3GRANULES;ORAL
02 22INJECTABLE;INTRATHECAL
03 4SOLUTION;ORAL
04 2SUSPENSION;ORAL
05 2TABLET, ORALLY DISINTEGRATING;ORAL
06 73TABLET;ORAL
01 29DISCN
02 74RX
03 3Blank
01 89BACLOFEN
02 1FLEQSUVY
03 4GABLOFEN
04 2KEMSTRO
05 5LIORESAL
06 3LYVISPAH
07 1OZOBAX
08 1OZOBAX DS
01 86No
02 17Yes
03 3Blank
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : Yes
TE Code :
Brand Name : LYVISPAH
Dosage Form : GRANULES;ORAL
Dosage Strength : 5MG/PACKET
Approval Date : 2021-11-22
Application Number : 215422
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
RLD : No
TE Code : AB
Brand Name : BACLOFEN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Approval Date : 2022-01-25
Application Number : 215885
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : Yes
TE Code :
Brand Name : LYVISPAH
Dosage Form : GRANULES;ORAL
Dosage Strength : 10MG/PACKET
Approval Date : 2021-11-22
Application Number : 215422
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
RLD : Yes
TE Code :
Brand Name : LYVISPAH
Dosage Form : GRANULES;ORAL
Dosage Strength : 20MG/PACKET
Approval Date : 2021-11-22
Application Number : 215422
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
RLD : No
TE Code : AB
Brand Name : BACLOFEN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Approval Date : 2022-01-25
Application Number : 215885
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
RLD : No
TE Code : AB
Brand Name : BACLOFEN
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG
Approval Date : 2022-01-25
Application Number : 215885
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code : AP
Brand Name : LIORESAL
Dosage Form : INJECTABLE;INTRATHECAL
Dosage Strength : 0.5MG/ML
Approval Date : 1992-06-17
Application Number : 20075
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP
RLD : Yes
TE Code : AP
Brand Name : LIORESAL
Dosage Form : INJECTABLE;INTRATHECAL
Dosage Strength : 2MG/ML
Approval Date : 1992-06-17
Application Number : 20075
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP
RLD : Yes
TE Code :
Brand Name : LIORESAL
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 17851
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : LIORESAL
Dosage Form : TABLET;ORAL
Dosage Strength : 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-20
Application Number : 17851
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
